nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—Topoisomerase Inhibitors—Doxorubicin—kidney cancer	0.289	1	CiPCiCtD
Etoposide—urinary bladder cancer—kidney cancer	0.0638	0.25	CtDrD
Etoposide—GSTT1—kidney cancer	0.061	0.372	CbGaD
Etoposide—muscle cancer—kidney cancer	0.054	0.212	CtDrD
Etoposide—testicular cancer—kidney cancer	0.0507	0.199	CtDrD
Etoposide—GSTP1—kidney cancer	0.0482	0.294	CbGaD
Etoposide—lung cancer—kidney cancer	0.0436	0.171	CtDrD
Etoposide—sarcoma—kidney cancer	0.0431	0.169	CtDrD
Etoposide—PTGS1—kidney cancer	0.0267	0.163	CbGaD
Etoposide—ABCC6—Dactinomycin—kidney cancer	0.0187	0.0941	CbGbCtD
Etoposide—PTGS2—kidney cancer	0.0152	0.0929	CbGaD
Etoposide—ABCB1—kidney cancer	0.013	0.079	CbGaD
Etoposide—ABCC6—Vinblastine—kidney cancer	0.0117	0.059	CbGbCtD
Etoposide—ABCC10—Gemcitabine—kidney cancer	0.0113	0.0568	CbGbCtD
Etoposide—ABCC10—Paclitaxel—kidney cancer	0.0102	0.0514	CbGbCtD
Etoposide—ABCC10—Vincristine—kidney cancer	0.0088	0.0443	CbGbCtD
Etoposide—UGT1A1—Pazopanib—kidney cancer	0.00734	0.0369	CbGbCtD
Etoposide—ABCC6—Doxorubicin—kidney cancer	0.0072	0.0362	CbGbCtD
Etoposide—ABCC3—Vincristine—kidney cancer	0.00553	0.0279	CbGbCtD
Etoposide—ABCC1—Dactinomycin—kidney cancer	0.00552	0.0278	CbGbCtD
Etoposide—ABCC10—Doxorubicin—kidney cancer	0.0055	0.0277	CbGbCtD
Etoposide—UGT1A1—Erlotinib—kidney cancer	0.00524	0.0264	CbGbCtD
Etoposide—UGT1A1—Sorafenib—kidney cancer	0.00426	0.0214	CbGbCtD
Etoposide—CYP3A5—Temsirolimus—kidney cancer	0.00426	0.0214	CbGbCtD
Etoposide—ABCG2—Pazopanib—kidney cancer	0.00404	0.0203	CbGbCtD
Etoposide—ABCC1—Paclitaxel—kidney cancer	0.00394	0.0198	CbGbCtD
Etoposide—TOP2A—Doxorubicin—kidney cancer	0.00383	0.0193	CbGbCtD
Etoposide—ABCG2—Dactinomycin—kidney cancer	0.00369	0.0186	CbGbCtD
Etoposide—ABCC3—Doxorubicin—kidney cancer	0.00346	0.0174	CbGbCtD
Etoposide—ABCC1—Vinblastine—kidney cancer	0.00346	0.0174	CbGbCtD
Etoposide—ABCC1—Vincristine—kidney cancer	0.0034	0.0171	CbGbCtD
Etoposide—ABCC2—Paclitaxel—kidney cancer	0.00292	0.0147	CbGbCtD
Etoposide—ABCG2—Erlotinib—kidney cancer	0.00288	0.0145	CbGbCtD
Etoposide—ABCB1—Temsirolimus—kidney cancer	0.00277	0.0139	CbGbCtD
Etoposide—ABCG2—Paclitaxel—kidney cancer	0.00264	0.0133	CbGbCtD
Etoposide—ABCC2—Sorafenib—kidney cancer	0.00259	0.013	CbGbCtD
Etoposide—ABCC2—Vinblastine—kidney cancer	0.00256	0.0129	CbGbCtD
Etoposide—ABCC2—Vincristine—kidney cancer	0.00251	0.0127	CbGbCtD
Etoposide—CYP3A4—Everolimus—kidney cancer	0.00246	0.0124	CbGbCtD
Etoposide—ABCG2—Sorafenib—kidney cancer	0.00234	0.0118	CbGbCtD
Etoposide—ABCG2—Vincristine—kidney cancer	0.00227	0.0114	CbGbCtD
Etoposide—CYP2C8—Pazopanib—kidney cancer	0.00215	0.0108	CbGbCtD
Etoposide—ABCC1—Doxorubicin—kidney cancer	0.00212	0.0107	CbGbCtD
Etoposide—ABCC2—Sunitinib—kidney cancer	0.0021	0.0106	CbGbCtD
Etoposide—GSTT1—urine—kidney cancer	0.0019	0.119	CbGeAlD
Etoposide—ABCG2—Sunitinib—kidney cancer	0.0019	0.00955	CbGbCtD
Etoposide—CYP1A2—Pazopanib—kidney cancer	0.00166	0.00838	CbGbCtD
Etoposide—CYP3A4—Temsirolimus—kidney cancer	0.00166	0.00836	CbGbCtD
Etoposide—CYP3A5—Erlotinib—kidney cancer	0.0016	0.00803	CbGbCtD
Etoposide—ABCC2—Doxorubicin—kidney cancer	0.00157	0.00791	CbGbCtD
Etoposide—CYP2C8—Erlotinib—kidney cancer	0.00153	0.00772	CbGbCtD
Etoposide—CYP3A5—Paclitaxel—kidney cancer	0.00146	0.00735	CbGbCtD
Etoposide—ABCB1—Pazopanib—kidney cancer	0.00146	0.00733	CbGbCtD
Etoposide—ABCG2—Doxorubicin—kidney cancer	0.00142	0.00715	CbGbCtD
Etoposide—CYP2C8—Paclitaxel—kidney cancer	0.0014	0.00707	CbGbCtD
Etoposide—ABCB1—Dactinomycin—kidney cancer	0.00133	0.0067	CbGbCtD
Etoposide—CYP3A5—Sorafenib—kidney cancer	0.0013	0.00653	CbGbCtD
Etoposide—CYP3A5—Vincristine—kidney cancer	0.00126	0.00634	CbGbCtD
Etoposide—CYP2C8—Sorafenib—kidney cancer	0.00125	0.00628	CbGbCtD
Etoposide—CYP1A2—Erlotinib—kidney cancer	0.00119	0.00598	CbGbCtD
Etoposide—UGT1A1—urine—kidney cancer	0.00111	0.0701	CbGeAlD
Etoposide—ABCB1—Gemcitabine—kidney cancer	0.00105	0.0053	CbGbCtD
Etoposide—CYP3A5—Sunitinib—kidney cancer	0.00105	0.00529	CbGbCtD
Etoposide—ABCB1—Erlotinib—kidney cancer	0.00104	0.00523	CbGbCtD
Etoposide—CYP1A2—Sorafenib—kidney cancer	0.000966	0.00486	CbGbCtD
Etoposide—ABCB1—Paclitaxel—kidney cancer	0.00095	0.00478	CbGbCtD
Etoposide—GSTP1—urine—kidney cancer	0.000875	0.0551	CbGeAlD
Etoposide—CYP3A4—Pazopanib—kidney cancer	0.000872	0.00439	CbGbCtD
Etoposide—ABCB1—Sorafenib—kidney cancer	0.000844	0.00425	CbGbCtD
Etoposide—ABCB1—Vinblastine—kidney cancer	0.000834	0.0042	CbGbCtD
Etoposide—ABCB1—Vincristine—kidney cancer	0.00082	0.00413	CbGbCtD
Etoposide—ABCB1—Sunitinib—kidney cancer	0.000684	0.00344	CbGbCtD
Etoposide—CYP3A4—Erlotinib—kidney cancer	0.000622	0.00313	CbGbCtD
Etoposide—CYP3A4—Paclitaxel—kidney cancer	0.000569	0.00287	CbGbCtD
Etoposide—ABCB1—Doxorubicin—kidney cancer	0.000512	0.00258	CbGbCtD
Etoposide—PTGS2—nephron—kidney cancer	0.000509	0.0321	CbGeAlD
Etoposide—CYP3A4—Sorafenib—kidney cancer	0.000506	0.00255	CbGbCtD
Etoposide—CYP3A4—Vinblastine—kidney cancer	0.0005	0.00251	CbGbCtD
Etoposide—CYP1A2—urine—kidney cancer	0.000493	0.031	CbGeAlD
Etoposide—CYP3A4—Vincristine—kidney cancer	0.000491	0.00247	CbGbCtD
Etoposide—GSTT1—renal system—kidney cancer	0.000464	0.0292	CbGeAlD
Etoposide—GSTT1—kidney—kidney cancer	0.000449	0.0282	CbGeAlD
Etoposide—CYP2E1—urine—kidney cancer	0.000443	0.0279	CbGeAlD
Etoposide—CYP3A4—Sunitinib—kidney cancer	0.00041	0.00206	CbGbCtD
Etoposide—ABCC6—renal system—kidney cancer	0.000377	0.0237	CbGeAlD
Etoposide—TOP2B—nephron tubule—kidney cancer	0.000376	0.0237	CbGeAlD
Etoposide—ABCC6—kidney—kidney cancer	0.000364	0.0229	CbGeAlD
Etoposide—CYP3A4—urine—kidney cancer	0.000357	0.0225	CbGeAlD
Etoposide—TOP2B—renal system—kidney cancer	0.000342	0.0215	CbGeAlD
Etoposide—TOP2B—kidney—kidney cancer	0.000331	0.0208	CbGeAlD
Etoposide—TOP2B—cortex of kidney—kidney cancer	0.000322	0.0203	CbGeAlD
Etoposide—CYP3A4—Doxorubicin—kidney cancer	0.000307	0.00155	CbGbCtD
Etoposide—TOP2B—gonad—kidney cancer	0.000307	0.0193	CbGeAlD
Etoposide—TOP2B—cardiac atrium—kidney cancer	0.000306	0.0193	CbGeAlD
Etoposide—UGT1A1—renal system—kidney cancer	0.000272	0.0172	CbGeAlD
Etoposide—UGT1A1—kidney—kidney cancer	0.000263	0.0166	CbGeAlD
Etoposide—GSTP1—nephron tubule—kidney cancer	0.000236	0.0148	CbGeAlD
Etoposide—ABCC3—renal system—kidney cancer	0.000215	0.0135	CbGeAlD
Etoposide—GSTP1—renal system—kidney cancer	0.000214	0.0135	CbGeAlD
Etoposide—ABCC10—renal system—kidney cancer	0.000214	0.0135	CbGeAlD
Etoposide—ABCC3—kidney—kidney cancer	0.000208	0.0131	CbGeAlD
Etoposide—GSTP1—kidney—kidney cancer	0.000207	0.013	CbGeAlD
Etoposide—ABCC10—kidney—kidney cancer	0.000207	0.013	CbGeAlD
Etoposide—GSTP1—cortex of kidney—kidney cancer	0.000202	0.0127	CbGeAlD
Etoposide—ABCC10—cortex of kidney—kidney cancer	0.000202	0.0127	CbGeAlD
Etoposide—GSTP1—gonad—kidney cancer	0.000192	0.0121	CbGeAlD
Etoposide—ABCC10—gonad—kidney cancer	0.000192	0.0121	CbGeAlD
Etoposide—GSTP1—cardiac atrium—kidney cancer	0.000192	0.0121	CbGeAlD
Etoposide—ABCC10—cardiac atrium—kidney cancer	0.000192	0.0121	CbGeAlD
Etoposide—ABCC2—nephron tubule—kidney cancer	0.000189	0.0119	CbGeAlD
Etoposide—TOP2A—Docetaxel—Paclitaxel—kidney cancer	0.000188	0.227	CbGdCrCtD
Etoposide—ABCC2—renal system—kidney cancer	0.000172	0.0108	CbGeAlD
Etoposide—ABCC2—kidney—kidney cancer	0.000166	0.0105	CbGeAlD
Etoposide—ABCC2—cortex of kidney—kidney cancer	0.000162	0.0102	CbGeAlD
Etoposide—ABCC1—cortex of kidney—kidney cancer	0.000143	0.00897	CbGeAlD
Etoposide—ABCG2—nephron tubule—kidney cancer	0.000138	0.00868	CbGeAlD
Etoposide—ABCC1—cardiac atrium—kidney cancer	0.000136	0.00853	CbGeAlD
Etoposide—CYP2C8—renal system—kidney cancer	0.000129	0.00811	CbGeAlD
Etoposide—CYP3A5—nephron tubule—kidney cancer	0.000128	0.00806	CbGeAlD
Etoposide—CYP2C8—kidney—kidney cancer	0.000125	0.00784	CbGeAlD
Etoposide—CYP1A2—renal system—kidney cancer	0.000121	0.00759	CbGeAlD
Etoposide—CYP2E1—nephron tubule—kidney cancer	0.000119	0.00751	CbGeAlD
Etoposide—CYP3A5—renal system—kidney cancer	0.000116	0.00732	CbGeAlD
Etoposide—CYP3A5—kidney—kidney cancer	0.000112	0.00708	CbGeAlD
Etoposide—CYP3A5—cortex of kidney—kidney cancer	0.00011	0.0069	CbGeAlD
Etoposide—CYP2E1—renal system—kidney cancer	0.000109	0.00683	CbGeAlD
Etoposide—CYP2E1—kidney—kidney cancer	0.000105	0.0066	CbGeAlD
Etoposide—PTGS1—renal system—kidney cancer	0.000105	0.00658	CbGeAlD
Etoposide—CYP2E1—cortex of kidney—kidney cancer	0.000102	0.00643	CbGeAlD
Etoposide—PTGS1—kidney—kidney cancer	0.000101	0.00636	CbGeAlD
Etoposide—PTGS2—renal system—kidney cancer	9.99e-05	0.00629	CbGeAlD
Etoposide—PTGS2—kidney—kidney cancer	9.66e-05	0.00608	CbGeAlD
Etoposide—TOP2A—Vindesine—Vinblastine—kidney cancer	9.54e-05	0.115	CbGdCrCtD
Etoposide—TOP2A—Vindesine—Vincristine—kidney cancer	9.54e-05	0.115	CbGdCrCtD
Etoposide—PTGS1—cardiac atrium—kidney cancer	9.36e-05	0.00589	CbGeAlD
Etoposide—TOP2A—Gefitinib—Erlotinib—kidney cancer	8.99e-05	0.109	CbGdCrCtD
Etoposide—CYP3A4—renal system—kidney cancer	8.73e-05	0.0055	CbGeAlD
Etoposide—CYP3A4—kidney—kidney cancer	8.44e-05	0.00531	CbGeAlD
Etoposide—ABCB1—nephron tubule—kidney cancer	6.8e-05	0.00428	CbGeAlD
Etoposide—ABCB1—renal system—kidney cancer	6.18e-05	0.00389	CbGeAlD
Etoposide—TOP2A—Vinorelbine—Vincristine—kidney cancer	6.02e-05	0.0728	CbGdCrCtD
Etoposide—TOP2A—Vinorelbine—Vinblastine—kidney cancer	6.02e-05	0.0728	CbGdCrCtD
Etoposide—ABCB1—kidney—kidney cancer	5.97e-05	0.00376	CbGeAlD
Etoposide—ABCB1—cortex of kidney—kidney cancer	5.82e-05	0.00366	CbGeAlD
Etoposide—ABCB1—gonad—kidney cancer	5.54e-05	0.00349	CbGeAlD
Etoposide—TOP2A—Vincristine—Vinblastine—kidney cancer	5.15e-05	0.0623	CbGdCrCtD
Etoposide—TOP2A—Vinblastine—Vincristine—kidney cancer	4.14e-05	0.0501	CbGdCrCtD
Etoposide—TOP2A—Cytarabine—Gemcitabine—kidney cancer	3.39e-05	0.0409	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Doxorubicin—kidney cancer	2.9e-05	0.0351	CbGdCrCtD
Etoposide—TOP2A—Epirubicin—Doxorubicin—kidney cancer	2.9e-05	0.0351	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Doxorubicin—kidney cancer	2.9e-05	0.0351	CbGdCrCtD
Etoposide—TOP2A—Azacitidine—Gemcitabine—kidney cancer	2.43e-05	0.0293	CbGdCrCtD
Etoposide—Vomiting—Everolimus—kidney cancer	2.15e-05	0.000389	CcSEcCtD
Etoposide—Anaemia—Paclitaxel—kidney cancer	2.15e-05	0.000389	CcSEcCtD
Etoposide—Urethral disorder—Capecitabine—kidney cancer	2.15e-05	0.000389	CcSEcCtD
Etoposide—Paraesthesia—Vincristine—kidney cancer	2.14e-05	0.000388	CcSEcCtD
Etoposide—Rash—Everolimus—kidney cancer	2.13e-05	0.000386	CcSEcCtD
Etoposide—Dermatitis—Everolimus—kidney cancer	2.13e-05	0.000386	CcSEcCtD
Etoposide—Headache—Vinblastine—kidney cancer	2.12e-05	0.000385	CcSEcCtD
Etoposide—Headache—Everolimus—kidney cancer	2.12e-05	0.000384	CcSEcCtD
Etoposide—Hypotension—Gemcitabine—kidney cancer	2.12e-05	0.000383	CcSEcCtD
Etoposide—Abdominal pain—Dactinomycin—kidney cancer	2.11e-05	0.000383	CcSEcCtD
Etoposide—Body temperature increased—Dactinomycin—kidney cancer	2.11e-05	0.000383	CcSEcCtD
Etoposide—Anaphylactoid reaction—Doxorubicin—kidney cancer	2.11e-05	0.000382	CcSEcCtD
Etoposide—Asthenia—Sorafenib—kidney cancer	2.1e-05	0.000381	CcSEcCtD
Etoposide—Malaise—Paclitaxel—kidney cancer	2.09e-05	0.00038	CcSEcCtD
Etoposide—Cardiac failure—Doxorubicin—kidney cancer	2.09e-05	0.000379	CcSEcCtD
Etoposide—Vertigo—Paclitaxel—kidney cancer	2.09e-05	0.000378	CcSEcCtD
Etoposide—Leukopenia—Paclitaxel—kidney cancer	2.08e-05	0.000377	CcSEcCtD
Etoposide—Hypersensitivity—Sunitinib—kidney cancer	2.08e-05	0.000377	CcSEcCtD
Etoposide—Decreased appetite—Vincristine—kidney cancer	2.07e-05	0.000376	CcSEcCtD
Etoposide—Pruritus—Sorafenib—kidney cancer	2.07e-05	0.000376	CcSEcCtD
Etoposide—Vomiting—Erlotinib—kidney cancer	2.07e-05	0.000376	CcSEcCtD
Etoposide—Erythema multiforme—Capecitabine—kidney cancer	2.07e-05	0.000375	CcSEcCtD
Etoposide—Gastrointestinal disorder—Vincristine—kidney cancer	2.06e-05	0.000373	CcSEcCtD
Etoposide—Fatigue—Vincristine—kidney cancer	2.06e-05	0.000373	CcSEcCtD
Etoposide—Rash—Erlotinib—kidney cancer	2.06e-05	0.000372	CcSEcCtD
Etoposide—Dermatitis—Erlotinib—kidney cancer	2.05e-05	0.000372	CcSEcCtD
Etoposide—Eye disorder—Capecitabine—kidney cancer	2.05e-05	0.000371	CcSEcCtD
Etoposide—Headache—Erlotinib—kidney cancer	2.04e-05	0.00037	CcSEcCtD
Etoposide—Loss of consciousness—Paclitaxel—kidney cancer	2.04e-05	0.00037	CcSEcCtD
Etoposide—Pain—Vincristine—kidney cancer	2.04e-05	0.00037	CcSEcCtD
Etoposide—Constipation—Vincristine—kidney cancer	2.04e-05	0.00037	CcSEcCtD
Etoposide—Paraesthesia—Gemcitabine—kidney cancer	2.03e-05	0.000368	CcSEcCtD
Etoposide—Flushing—Capecitabine—kidney cancer	2.03e-05	0.000368	CcSEcCtD
Etoposide—Cardiac disorder—Capecitabine—kidney cancer	2.03e-05	0.000368	CcSEcCtD
Etoposide—Cough—Paclitaxel—kidney cancer	2.03e-05	0.000367	CcSEcCtD
Etoposide—Asthenia—Sunitinib—kidney cancer	2.02e-05	0.000367	CcSEcCtD
Etoposide—Dyspnoea—Gemcitabine—kidney cancer	2.02e-05	0.000366	CcSEcCtD
Etoposide—Nausea—Vinblastine—kidney cancer	2.01e-05	0.000365	CcSEcCtD
Etoposide—Somnolence—Gemcitabine—kidney cancer	2.01e-05	0.000365	CcSEcCtD
Etoposide—Convulsion—Paclitaxel—kidney cancer	2.01e-05	0.000365	CcSEcCtD
Etoposide—Nausea—Everolimus—kidney cancer	2.01e-05	0.000364	CcSEcCtD
Etoposide—Diarrhoea—Sorafenib—kidney cancer	2.01e-05	0.000364	CcSEcCtD
Etoposide—Hypertension—Paclitaxel—kidney cancer	2.01e-05	0.000363	CcSEcCtD
Etoposide—Pruritus—Sunitinib—kidney cancer	2e-05	0.000362	CcSEcCtD
Etoposide—Angiopathy—Capecitabine—kidney cancer	1.99e-05	0.00036	CcSEcCtD
Etoposide—Immune system disorder—Capecitabine—kidney cancer	1.98e-05	0.000358	CcSEcCtD
Etoposide—Chest pain—Paclitaxel—kidney cancer	1.98e-05	0.000358	CcSEcCtD
Etoposide—Mediastinal disorder—Capecitabine—kidney cancer	1.97e-05	0.000358	CcSEcCtD
Etoposide—Decreased appetite—Gemcitabine—kidney cancer	1.97e-05	0.000357	CcSEcCtD
Etoposide—Hypersensitivity—Dactinomycin—kidney cancer	1.97e-05	0.000357	CcSEcCtD
Etoposide—Chills—Capecitabine—kidney cancer	1.96e-05	0.000356	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	1.96e-05	0.000356	CcSEcCtD
Etoposide—Gastrointestinal disorder—Gemcitabine—kidney cancer	1.95e-05	0.000354	CcSEcCtD
Etoposide—Discomfort—Paclitaxel—kidney cancer	1.95e-05	0.000354	CcSEcCtD
Etoposide—Fatigue—Gemcitabine—kidney cancer	1.95e-05	0.000354	CcSEcCtD
Etoposide—Gastrointestinal pain—Vincristine—kidney cancer	1.95e-05	0.000354	CcSEcCtD
Etoposide—Cardiac arrest—Doxorubicin—kidney cancer	1.94e-05	0.000352	CcSEcCtD
Etoposide—Dizziness—Sorafenib—kidney cancer	1.94e-05	0.000351	CcSEcCtD
Etoposide—Pain—Gemcitabine—kidney cancer	1.94e-05	0.000351	CcSEcCtD
Etoposide—Constipation—Gemcitabine—kidney cancer	1.94e-05	0.000351	CcSEcCtD
Etoposide—Nausea—Erlotinib—kidney cancer	1.94e-05	0.000351	CcSEcCtD
Etoposide—Alopecia—Capecitabine—kidney cancer	1.93e-05	0.000351	CcSEcCtD
Etoposide—Diarrhoea—Sunitinib—kidney cancer	1.93e-05	0.00035	CcSEcCtD
Etoposide—Asthenia—Dactinomycin—kidney cancer	1.92e-05	0.000347	CcSEcCtD
Etoposide—Confusional state—Paclitaxel—kidney cancer	1.91e-05	0.000346	CcSEcCtD
Etoposide—Anaphylactic shock—Paclitaxel—kidney cancer	1.9e-05	0.000344	CcSEcCtD
Etoposide—Abdominal pain—Vincristine—kidney cancer	1.89e-05	0.000342	CcSEcCtD
Etoposide—Body temperature increased—Vincristine—kidney cancer	1.89e-05	0.000342	CcSEcCtD
Etoposide—Infection—Paclitaxel—kidney cancer	1.88e-05	0.000341	CcSEcCtD
Etoposide—Dysgeusia—Capecitabine—kidney cancer	1.87e-05	0.000338	CcSEcCtD
Etoposide—Dizziness—Sunitinib—kidney cancer	1.87e-05	0.000338	CcSEcCtD
Etoposide—Feeling abnormal—Gemcitabine—kidney cancer	1.87e-05	0.000338	CcSEcCtD
Etoposide—Vomiting—Sorafenib—kidney cancer	1.86e-05	0.000338	CcSEcCtD
Etoposide—Thrombocytopenia—Paclitaxel—kidney cancer	1.86e-05	0.000336	CcSEcCtD
Etoposide—Tachycardia—Paclitaxel—kidney cancer	1.85e-05	0.000335	CcSEcCtD
Etoposide—Rash—Sorafenib—kidney cancer	1.85e-05	0.000335	CcSEcCtD
Etoposide—Dermatitis—Sorafenib—kidney cancer	1.85e-05	0.000335	CcSEcCtD
Etoposide—Back pain—Capecitabine—kidney cancer	1.84e-05	0.000334	CcSEcCtD
Etoposide—Skin disorder—Paclitaxel—kidney cancer	1.84e-05	0.000334	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	1.84e-05	0.000333	CcSEcCtD
Etoposide—Headache—Sorafenib—kidney cancer	1.84e-05	0.000333	CcSEcCtD
Etoposide—Muscle spasms—Capecitabine—kidney cancer	1.83e-05	0.000332	CcSEcCtD
Etoposide—Hyperhidrosis—Paclitaxel—kidney cancer	1.83e-05	0.000332	CcSEcCtD
Etoposide—Diarrhoea—Dactinomycin—kidney cancer	1.83e-05	0.000331	CcSEcCtD
Etoposide—Anorexia—Paclitaxel—kidney cancer	1.81e-05	0.000327	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Doxorubicin—kidney cancer	1.8e-05	0.000326	CcSEcCtD
Etoposide—Vomiting—Sunitinib—kidney cancer	1.79e-05	0.000325	CcSEcCtD
Etoposide—Body temperature increased—Gemcitabine—kidney cancer	1.79e-05	0.000324	CcSEcCtD
Etoposide—Rash—Sunitinib—kidney cancer	1.78e-05	0.000322	CcSEcCtD
Etoposide—Dermatitis—Sunitinib—kidney cancer	1.78e-05	0.000322	CcSEcCtD
Etoposide—Hypotension—Paclitaxel—kidney cancer	1.77e-05	0.000321	CcSEcCtD
Etoposide—Ill-defined disorder—Capecitabine—kidney cancer	1.77e-05	0.000321	CcSEcCtD
Etoposide—Headache—Sunitinib—kidney cancer	1.77e-05	0.00032	CcSEcCtD
Etoposide—Dysphagia—Doxorubicin—kidney cancer	1.76e-05	0.00032	CcSEcCtD
Etoposide—Anaemia—Capecitabine—kidney cancer	1.76e-05	0.000319	CcSEcCtD
Etoposide—Hypersensitivity—Vincristine—kidney cancer	1.76e-05	0.000319	CcSEcCtD
Etoposide—Nausea—Sorafenib—kidney cancer	1.74e-05	0.000316	CcSEcCtD
Etoposide—Malaise—Capecitabine—kidney cancer	1.72e-05	0.000312	CcSEcCtD
Etoposide—Vertigo—Capecitabine—kidney cancer	1.71e-05	0.00031	CcSEcCtD
Etoposide—Asthenia—Vincristine—kidney cancer	1.71e-05	0.00031	CcSEcCtD
Etoposide—Leukopenia—Capecitabine—kidney cancer	1.71e-05	0.000309	CcSEcCtD
Etoposide—Paraesthesia—Paclitaxel—kidney cancer	1.7e-05	0.000308	CcSEcCtD
Etoposide—Vomiting—Dactinomycin—kidney cancer	1.7e-05	0.000308	CcSEcCtD
Etoposide—Dyspnoea—Paclitaxel—kidney cancer	1.69e-05	0.000306	CcSEcCtD
Etoposide—Somnolence—Paclitaxel—kidney cancer	1.69e-05	0.000305	CcSEcCtD
Etoposide—Rash—Dactinomycin—kidney cancer	1.68e-05	0.000305	CcSEcCtD
Etoposide—Nausea—Sunitinib—kidney cancer	1.68e-05	0.000304	CcSEcCtD
Etoposide—Loss of consciousness—Capecitabine—kidney cancer	1.68e-05	0.000304	CcSEcCtD
Etoposide—Pancytopenia—Doxorubicin—kidney cancer	1.67e-05	0.000303	CcSEcCtD
Etoposide—Cough—Capecitabine—kidney cancer	1.66e-05	0.000301	CcSEcCtD
Etoposide—Neutropenia—Doxorubicin—kidney cancer	1.65e-05	0.000299	CcSEcCtD
Etoposide—Decreased appetite—Paclitaxel—kidney cancer	1.65e-05	0.000299	CcSEcCtD
Etoposide—Hypertension—Capecitabine—kidney cancer	1.65e-05	0.000298	CcSEcCtD
Etoposide—Gastrointestinal disorder—Paclitaxel—kidney cancer	1.64e-05	0.000297	CcSEcCtD
Etoposide—Fatigue—Paclitaxel—kidney cancer	1.63e-05	0.000296	CcSEcCtD
Etoposide—Diarrhoea—Vincristine—kidney cancer	1.63e-05	0.000296	CcSEcCtD
Etoposide—Asthenia—Gemcitabine—kidney cancer	1.62e-05	0.000294	CcSEcCtD
Etoposide—Chest pain—Capecitabine—kidney cancer	1.62e-05	0.000294	CcSEcCtD
Etoposide—Pain—Paclitaxel—kidney cancer	1.62e-05	0.000294	CcSEcCtD
Etoposide—Constipation—Paclitaxel—kidney cancer	1.62e-05	0.000294	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	1.61e-05	0.000292	CcSEcCtD
Etoposide—Discomfort—Capecitabine—kidney cancer	1.6e-05	0.000291	CcSEcCtD
Etoposide—Pruritus—Gemcitabine—kidney cancer	1.6e-05	0.00029	CcSEcCtD
Etoposide—Nausea—Dactinomycin—kidney cancer	1.59e-05	0.000288	CcSEcCtD
Etoposide—Pneumonia—Doxorubicin—kidney cancer	1.58e-05	0.000287	CcSEcCtD
Etoposide—Dizziness—Vincristine—kidney cancer	1.58e-05	0.000286	CcSEcCtD
Etoposide—Infestation NOS—Doxorubicin—kidney cancer	1.57e-05	0.000285	CcSEcCtD
Etoposide—Infestation—Doxorubicin—kidney cancer	1.57e-05	0.000285	CcSEcCtD
Etoposide—Confusional state—Capecitabine—kidney cancer	1.57e-05	0.000284	CcSEcCtD
Etoposide—Feeling abnormal—Paclitaxel—kidney cancer	1.56e-05	0.000283	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	1.56e-05	0.000282	CcSEcCtD
Etoposide—Gastrointestinal pain—Paclitaxel—kidney cancer	1.55e-05	0.000281	CcSEcCtD
Etoposide—Diarrhoea—Gemcitabine—kidney cancer	1.55e-05	0.000281	CcSEcCtD
Etoposide—Renal failure—Doxorubicin—kidney cancer	1.55e-05	0.00028	CcSEcCtD
Etoposide—Infection—Capecitabine—kidney cancer	1.55e-05	0.00028	CcSEcCtD
Etoposide—Neuropathy peripheral—Doxorubicin—kidney cancer	1.54e-05	0.000279	CcSEcCtD
Etoposide—Jaundice—Doxorubicin—kidney cancer	1.53e-05	0.000278	CcSEcCtD
Etoposide—Stomatitis—Doxorubicin—kidney cancer	1.53e-05	0.000278	CcSEcCtD
Etoposide—Thrombocytopenia—Capecitabine—kidney cancer	1.52e-05	0.000276	CcSEcCtD
Etoposide—Tachycardia—Capecitabine—kidney cancer	1.52e-05	0.000275	CcSEcCtD
Etoposide—Vomiting—Vincristine—kidney cancer	1.52e-05	0.000275	CcSEcCtD
Etoposide—Skin disorder—Capecitabine—kidney cancer	1.51e-05	0.000274	CcSEcCtD
Etoposide—Urticaria—Paclitaxel—kidney cancer	1.51e-05	0.000273	CcSEcCtD
Etoposide—Rash—Vincristine—kidney cancer	1.5e-05	0.000273	CcSEcCtD
Etoposide—Hyperhidrosis—Capecitabine—kidney cancer	1.5e-05	0.000273	CcSEcCtD
Etoposide—Dermatitis—Vincristine—kidney cancer	1.5e-05	0.000272	CcSEcCtD
Etoposide—Abdominal pain—Paclitaxel—kidney cancer	1.5e-05	0.000272	CcSEcCtD
Etoposide—Body temperature increased—Paclitaxel—kidney cancer	1.5e-05	0.000272	CcSEcCtD
Etoposide—Headache—Vincristine—kidney cancer	1.5e-05	0.000271	CcSEcCtD
Etoposide—Hepatobiliary disease—Doxorubicin—kidney cancer	1.49e-05	0.000269	CcSEcCtD
Etoposide—Anorexia—Capecitabine—kidney cancer	1.48e-05	0.000269	CcSEcCtD
Etoposide—Agranulocytosis—Doxorubicin—kidney cancer	1.47e-05	0.000266	CcSEcCtD
Etoposide—Hypotension—Capecitabine—kidney cancer	1.45e-05	0.000263	CcSEcCtD
Etoposide—Vomiting—Gemcitabine—kidney cancer	1.44e-05	0.000261	CcSEcCtD
Etoposide—Rash—Gemcitabine—kidney cancer	1.43e-05	0.000259	CcSEcCtD
Etoposide—Dermatitis—Gemcitabine—kidney cancer	1.43e-05	0.000258	CcSEcCtD
Etoposide—Headache—Gemcitabine—kidney cancer	1.42e-05	0.000257	CcSEcCtD
Etoposide—Nausea—Vincristine—kidney cancer	1.42e-05	0.000257	CcSEcCtD
Etoposide—Hypoaesthesia—Doxorubicin—kidney cancer	1.4e-05	0.000255	CcSEcCtD
Etoposide—Paraesthesia—Capecitabine—kidney cancer	1.4e-05	0.000253	CcSEcCtD
Etoposide—Hypersensitivity—Paclitaxel—kidney cancer	1.4e-05	0.000253	CcSEcCtD
Etoposide—Urinary tract disorder—Doxorubicin—kidney cancer	1.39e-05	0.000253	CcSEcCtD
Etoposide—Dyspnoea—Capecitabine—kidney cancer	1.39e-05	0.000251	CcSEcCtD
Etoposide—Urethral disorder—Doxorubicin—kidney cancer	1.38e-05	0.000251	CcSEcCtD
Etoposide—Asthenia—Paclitaxel—kidney cancer	1.36e-05	0.000246	CcSEcCtD
Etoposide—Decreased appetite—Capecitabine—kidney cancer	1.35e-05	0.000245	CcSEcCtD
Etoposide—Nausea—Gemcitabine—kidney cancer	1.34e-05	0.000244	CcSEcCtD
Etoposide—Gastrointestinal disorder—Capecitabine—kidney cancer	1.34e-05	0.000243	CcSEcCtD
Etoposide—Fatigue—Capecitabine—kidney cancer	1.34e-05	0.000243	CcSEcCtD
Etoposide—Pruritus—Paclitaxel—kidney cancer	1.34e-05	0.000243	CcSEcCtD
Etoposide—Erythema multiforme—Doxorubicin—kidney cancer	1.33e-05	0.000242	CcSEcCtD
Etoposide—Pain—Capecitabine—kidney cancer	1.33e-05	0.000241	CcSEcCtD
Etoposide—Constipation—Capecitabine—kidney cancer	1.33e-05	0.000241	CcSEcCtD
Etoposide—Eye disorder—Doxorubicin—kidney cancer	1.32e-05	0.000239	CcSEcCtD
Etoposide—Flushing—Doxorubicin—kidney cancer	1.31e-05	0.000237	CcSEcCtD
Etoposide—Cardiac disorder—Doxorubicin—kidney cancer	1.31e-05	0.000237	CcSEcCtD
Etoposide—Diarrhoea—Paclitaxel—kidney cancer	1.3e-05	0.000235	CcSEcCtD
Etoposide—Feeling abnormal—Capecitabine—kidney cancer	1.28e-05	0.000232	CcSEcCtD
Etoposide—Angiopathy—Doxorubicin—kidney cancer	1.28e-05	0.000232	CcSEcCtD
Etoposide—Immune system disorder—Doxorubicin—kidney cancer	1.27e-05	0.000231	CcSEcCtD
Etoposide—Gastrointestinal pain—Capecitabine—kidney cancer	1.27e-05	0.000231	CcSEcCtD
Etoposide—Mediastinal disorder—Doxorubicin—kidney cancer	1.27e-05	0.000231	CcSEcCtD
Etoposide—Chills—Doxorubicin—kidney cancer	1.27e-05	0.00023	CcSEcCtD
Etoposide—Dizziness—Paclitaxel—kidney cancer	1.25e-05	0.000227	CcSEcCtD
Etoposide—Alopecia—Doxorubicin—kidney cancer	1.25e-05	0.000226	CcSEcCtD
Etoposide—Urticaria—Capecitabine—kidney cancer	1.24e-05	0.000224	CcSEcCtD
Etoposide—Abdominal pain—Capecitabine—kidney cancer	1.23e-05	0.000223	CcSEcCtD
Etoposide—Body temperature increased—Capecitabine—kidney cancer	1.23e-05	0.000223	CcSEcCtD
Etoposide—Vomiting—Paclitaxel—kidney cancer	1.21e-05	0.000218	CcSEcCtD
Etoposide—Dysgeusia—Doxorubicin—kidney cancer	1.2e-05	0.000218	CcSEcCtD
Etoposide—Rash—Paclitaxel—kidney cancer	1.2e-05	0.000217	CcSEcCtD
Etoposide—Dermatitis—Paclitaxel—kidney cancer	1.19e-05	0.000216	CcSEcCtD
Etoposide—Back pain—Doxorubicin—kidney cancer	1.19e-05	0.000215	CcSEcCtD
Etoposide—Headache—Paclitaxel—kidney cancer	1.19e-05	0.000215	CcSEcCtD
Etoposide—Muscle spasms—Doxorubicin—kidney cancer	1.18e-05	0.000214	CcSEcCtD
Etoposide—Hypersensitivity—Capecitabine—kidney cancer	1.15e-05	0.000208	CcSEcCtD
Etoposide—Ill-defined disorder—Doxorubicin—kidney cancer	1.14e-05	0.000207	CcSEcCtD
Etoposide—Anaemia—Doxorubicin—kidney cancer	1.14e-05	0.000206	CcSEcCtD
Etoposide—Nausea—Paclitaxel—kidney cancer	1.13e-05	0.000204	CcSEcCtD
Etoposide—Asthenia—Capecitabine—kidney cancer	1.12e-05	0.000202	CcSEcCtD
Etoposide—Malaise—Doxorubicin—kidney cancer	1.11e-05	0.000201	CcSEcCtD
Etoposide—Vertigo—Doxorubicin—kidney cancer	1.1e-05	0.0002	CcSEcCtD
Etoposide—Pruritus—Capecitabine—kidney cancer	1.1e-05	0.000199	CcSEcCtD
Etoposide—Leukopenia—Doxorubicin—kidney cancer	1.1e-05	0.000199	CcSEcCtD
Etoposide—Loss of consciousness—Doxorubicin—kidney cancer	1.08e-05	0.000196	CcSEcCtD
Etoposide—Cough—Doxorubicin—kidney cancer	1.07e-05	0.000194	CcSEcCtD
Etoposide—Convulsion—Doxorubicin—kidney cancer	1.06e-05	0.000193	CcSEcCtD
Etoposide—Diarrhoea—Capecitabine—kidney cancer	1.06e-05	0.000193	CcSEcCtD
Etoposide—Hypertension—Doxorubicin—kidney cancer	1.06e-05	0.000192	CcSEcCtD
Etoposide—Chest pain—Doxorubicin—kidney cancer	1.05e-05	0.00019	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	1.04e-05	0.000188	CcSEcCtD
Etoposide—Discomfort—Doxorubicin—kidney cancer	1.03e-05	0.000187	CcSEcCtD
Etoposide—Dizziness—Capecitabine—kidney cancer	1.03e-05	0.000186	CcSEcCtD
Etoposide—Confusional state—Doxorubicin—kidney cancer	1.01e-05	0.000183	CcSEcCtD
Etoposide—Anaphylactic shock—Doxorubicin—kidney cancer	1e-05	0.000182	CcSEcCtD
Etoposide—Infection—Doxorubicin—kidney cancer	9.96e-06	0.000181	CcSEcCtD
Etoposide—Vomiting—Capecitabine—kidney cancer	9.89e-06	0.000179	CcSEcCtD
Etoposide—Thrombocytopenia—Doxorubicin—kidney cancer	9.82e-06	0.000178	CcSEcCtD
Etoposide—Rash—Capecitabine—kidney cancer	9.81e-06	0.000178	CcSEcCtD
Etoposide—Dermatitis—Capecitabine—kidney cancer	9.8e-06	0.000178	CcSEcCtD
Etoposide—Tachycardia—Doxorubicin—kidney cancer	9.79e-06	0.000177	CcSEcCtD
Etoposide—Headache—Capecitabine—kidney cancer	9.75e-06	0.000177	CcSEcCtD
Etoposide—Skin disorder—Doxorubicin—kidney cancer	9.74e-06	0.000177	CcSEcCtD
Etoposide—Hyperhidrosis—Doxorubicin—kidney cancer	9.69e-06	0.000176	CcSEcCtD
Etoposide—Anorexia—Doxorubicin—kidney cancer	9.56e-06	0.000173	CcSEcCtD
Etoposide—Hypotension—Doxorubicin—kidney cancer	9.37e-06	0.00017	CcSEcCtD
Etoposide—Nausea—Capecitabine—kidney cancer	9.24e-06	0.000167	CcSEcCtD
Etoposide—Paraesthesia—Doxorubicin—kidney cancer	9e-06	0.000163	CcSEcCtD
Etoposide—Dyspnoea—Doxorubicin—kidney cancer	8.94e-06	0.000162	CcSEcCtD
Etoposide—Somnolence—Doxorubicin—kidney cancer	8.92e-06	0.000162	CcSEcCtD
Etoposide—Decreased appetite—Doxorubicin—kidney cancer	8.72e-06	0.000158	CcSEcCtD
Etoposide—Gastrointestinal disorder—Doxorubicin—kidney cancer	8.66e-06	0.000157	CcSEcCtD
Etoposide—Fatigue—Doxorubicin—kidney cancer	8.65e-06	0.000157	CcSEcCtD
Etoposide—Pain—Doxorubicin—kidney cancer	8.58e-06	0.000155	CcSEcCtD
Etoposide—Constipation—Doxorubicin—kidney cancer	8.58e-06	0.000155	CcSEcCtD
Etoposide—Feeling abnormal—Doxorubicin—kidney cancer	8.26e-06	0.00015	CcSEcCtD
Etoposide—Gastrointestinal pain—Doxorubicin—kidney cancer	8.2e-06	0.000149	CcSEcCtD
Etoposide—Urticaria—Doxorubicin—kidney cancer	7.97e-06	0.000144	CcSEcCtD
Etoposide—Abdominal pain—Doxorubicin—kidney cancer	7.93e-06	0.000144	CcSEcCtD
Etoposide—Body temperature increased—Doxorubicin—kidney cancer	7.93e-06	0.000144	CcSEcCtD
Etoposide—Hypersensitivity—Doxorubicin—kidney cancer	7.39e-06	0.000134	CcSEcCtD
Etoposide—Asthenia—Doxorubicin—kidney cancer	7.19e-06	0.00013	CcSEcCtD
Etoposide—Pruritus—Doxorubicin—kidney cancer	7.09e-06	0.000129	CcSEcCtD
Etoposide—Diarrhoea—Doxorubicin—kidney cancer	6.86e-06	0.000124	CcSEcCtD
Etoposide—Dizziness—Doxorubicin—kidney cancer	6.63e-06	0.00012	CcSEcCtD
Etoposide—Vomiting—Doxorubicin—kidney cancer	6.38e-06	0.000116	CcSEcCtD
Etoposide—Rash—Doxorubicin—kidney cancer	6.32e-06	0.000115	CcSEcCtD
Etoposide—Dermatitis—Doxorubicin—kidney cancer	6.32e-06	0.000114	CcSEcCtD
Etoposide—Headache—Doxorubicin—kidney cancer	6.28e-06	0.000114	CcSEcCtD
Etoposide—Nausea—Doxorubicin—kidney cancer	5.96e-06	0.000108	CcSEcCtD
Etoposide—CYP3A4—Metabolism—CCBL1—kidney cancer	2.38e-06	0.000115	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—SLC5A5—kidney cancer	2.38e-06	0.000115	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.37e-06	0.000114	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—GSTP1—kidney cancer	2.35e-06	0.000113	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—TP53—kidney cancer	2.35e-06	0.000113	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GPC3—kidney cancer	2.34e-06	0.000113	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.3e-06	0.000111	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—SLC2A1—kidney cancer	2.3e-06	0.000111	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.28e-06	0.00011	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CA2—kidney cancer	2.28e-06	0.00011	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—GSTP1—kidney cancer	2.27e-06	0.000109	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ITPR2—kidney cancer	2.27e-06	0.000109	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ITPR2—kidney cancer	2.26e-06	0.000109	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.24e-06	0.000108	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.23e-06	0.000107	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—ABCB1—kidney cancer	2.23e-06	0.000107	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.22e-06	0.000107	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ALAD—kidney cancer	2.22e-06	0.000107	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ACHE—kidney cancer	2.2e-06	0.000106	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GSTT1—kidney cancer	2.2e-06	0.000106	CbGpPWpGaD
Etoposide—PTGS2—Disease—SLC2A1—kidney cancer	2.18e-06	0.000105	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.18e-06	0.000105	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ST3GAL2—kidney cancer	2.16e-06	0.000104	CbGpPWpGaD
Etoposide—PTGS2—Disease—JUNB—kidney cancer	2.16e-06	0.000104	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—GSTM1—kidney cancer	2.16e-06	0.000104	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CA9—kidney cancer	2.16e-06	0.000104	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—ABCB1—kidney cancer	2.15e-06	0.000103	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.13e-06	0.000103	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PTEN—kidney cancer	2.12e-06	0.000102	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ALDH1A1—kidney cancer	2.12e-06	0.000102	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CRABP1—kidney cancer	2.11e-06	0.000102	CbGpPWpGaD
Etoposide—ABCC1—Disease—HIF1A—kidney cancer	2.1e-06	0.000101	CbGpPWpGaD
Etoposide—ABCC1—Disease—TSC2—kidney cancer	2.09e-06	0.000101	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—GSTM1—kidney cancer	2.08e-06	0.0001	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—SCARB1—kidney cancer	2.08e-06	0.0001	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.07e-06	9.98e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ACHE—kidney cancer	2.07e-06	9.96e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GSTT1—kidney cancer	2.07e-06	9.96e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PPAT—kidney cancer	2.07e-06	9.95e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.07e-06	9.95e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GSTT1—kidney cancer	2.06e-06	9.94e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ACHE—kidney cancer	2.06e-06	9.94e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PTGS1—kidney cancer	2.06e-06	9.91e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—CYP1A1—kidney cancer	2.05e-06	9.87e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PGK1—kidney cancer	2.03e-06	9.77e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—SLC5A3—kidney cancer	2.03e-06	9.77e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PSMD7—kidney cancer	2.02e-06	9.72e-05	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.01e-06	9.7e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GSTP1—kidney cancer	2e-06	9.61e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—LDHB—kidney cancer	1.99e-06	9.58e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—CYP1A1—kidney cancer	1.98e-06	9.52e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ITPR2—kidney cancer	1.96e-06	9.44e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—SCARB1—kidney cancer	1.96e-06	9.43e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—SCARB1—kidney cancer	1.95e-06	9.41e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.95e-06	9.37e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTGS1—kidney cancer	1.94e-06	9.33e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTGS1—kidney cancer	1.93e-06	9.31e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—APRT—kidney cancer	1.92e-06	9.25e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—FH—kidney cancer	1.92e-06	9.25e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GSTP1—kidney cancer	1.92e-06	9.24e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—BCHE—kidney cancer	1.91e-06	9.22e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PSMD7—kidney cancer	1.9e-06	9.15e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PSMD7—kidney cancer	1.9e-06	9.13e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—SLC5A5—kidney cancer	1.89e-06	9.1e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—ABCB1—kidney cancer	1.89e-06	9.1e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—POMC—kidney cancer	1.88e-06	9.06e-05	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.85e-06	8.91e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—APC—kidney cancer	1.85e-06	8.9e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—KIT—kidney cancer	1.85e-06	8.9e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CRABP1—kidney cancer	1.84e-06	8.84e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GSTM1—kidney cancer	1.83e-06	8.83e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—SLC2A1—kidney cancer	1.83e-06	8.79e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—ABCB1—kidney cancer	1.82e-06	8.74e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.81e-06	8.7e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GPC3—kidney cancer	1.81e-06	8.69e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—BCHE—kidney cancer	1.8e-06	8.67e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—BCHE—kidney cancer	1.8e-06	8.66e-05	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.79e-06	8.62e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSTT1—kidney cancer	1.79e-06	8.61e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ACHE—kidney cancer	1.79e-06	8.61e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—SLC5A5—kidney cancer	1.78e-06	8.57e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—SLC5A5—kidney cancer	1.78e-06	8.55e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GSTM1—kidney cancer	1.76e-06	8.49e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN2B—kidney cancer	1.76e-06	8.48e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CA2—kidney cancer	1.76e-06	8.46e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CYP1A1—kidney cancer	1.74e-06	8.37e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—BRAF—kidney cancer	1.74e-06	8.37e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CA9—kidney cancer	1.72e-06	8.3e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—SLC2A1—kidney cancer	1.72e-06	8.28e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—SLC2A1—kidney cancer	1.72e-06	8.26e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALAD—kidney cancer	1.71e-06	8.24e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ITPR2—kidney cancer	1.71e-06	8.22e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—SCARB1—kidney cancer	1.69e-06	8.15e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.69e-06	8.12e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTGS1—kidney cancer	1.67e-06	8.07e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CYP1A1—kidney cancer	1.67e-06	8.05e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.67e-06	8.04e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PSMD7—kidney cancer	1.64e-06	7.91e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.63e-06	7.86e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.62e-06	7.82e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PGK1—kidney cancer	1.57e-06	7.54e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.57e-06	7.54e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTT1—kidney cancer	1.56e-06	7.5e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ACHE—kidney cancer	1.56e-06	7.5e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—BCHE—kidney cancer	1.56e-06	7.5e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.54e-06	7.44e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—SLC5A5—kidney cancer	1.54e-06	7.41e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—LDHB—kidney cancer	1.54e-06	7.39e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—POMC—kidney cancer	1.53e-06	7.36e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GSTP1—kidney cancer	1.52e-06	7.33e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PTGS2—kidney cancer	1.5e-06	7.22e-05	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PIK3CA—kidney cancer	1.49e-06	7.19e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—SLC2A1—kidney cancer	1.49e-06	7.15e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—SCARB1—kidney cancer	1.47e-06	7.1e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—POMC—kidney cancer	1.47e-06	7.1e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CRABP1—kidney cancer	1.47e-06	7.06e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTGS1—kidney cancer	1.46e-06	7.03e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—RAF1—kidney cancer	1.45e-06	6.99e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ABCB1—kidney cancer	1.44e-06	6.94e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.44e-06	6.94e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—ERBB2—kidney cancer	1.44e-06	6.91e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GSTP1—kidney cancer	1.43e-06	6.9e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PSMD7—kidney cancer	1.43e-06	6.89e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GSTP1—kidney cancer	1.43e-06	6.89e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MTOR—kidney cancer	1.42e-06	6.82e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—CD4—kidney cancer	1.41e-06	6.81e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—HIF1A—kidney cancer	1.41e-06	6.78e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—TSC2—kidney cancer	1.4e-06	6.76e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTGS2—kidney cancer	1.4e-06	6.76e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GSTM1—kidney cancer	1.4e-06	6.74e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.37e-06	6.61e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ITPR2—kidney cancer	1.36e-06	6.56e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ABCB1—kidney cancer	1.36e-06	6.53e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—BCHE—kidney cancer	1.36e-06	6.53e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ABCB1—kidney cancer	1.35e-06	6.52e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—SLC5A5—kidney cancer	1.34e-06	6.45e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CA9—kidney cancer	1.33e-06	6.41e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—CDKN1B—kidney cancer	1.33e-06	6.4e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CYP1A1—kidney cancer	1.33e-06	6.39e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GSTM1—kidney cancer	1.32e-06	6.34e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GSTM1—kidney cancer	1.31e-06	6.33e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PTEN—kidney cancer	1.31e-06	6.3e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—POMC—kidney cancer	1.3e-06	6.24e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—SLC2A1—kidney cancer	1.29e-06	6.23e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.26e-06	6.05e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.26e-06	6.05e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—CTNNB1—kidney cancer	1.26e-06	6.05e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CYP1A1—kidney cancer	1.25e-06	6.01e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CYP1A1—kidney cancer	1.25e-06	6e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—POMC—kidney cancer	1.25e-06	6e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ACHE—kidney cancer	1.24e-06	5.99e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTT1—kidney cancer	1.24e-06	5.99e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—KIT—kidney cancer	1.24e-06	5.97e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—APC—kidney cancer	1.24e-06	5.97e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSTP1—kidney cancer	1.24e-06	5.97e-05	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.23e-06	5.94e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTEN—kidney cancer	1.22e-06	5.89e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTGS2—kidney cancer	1.22e-06	5.87e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—SCARB1—kidney cancer	1.18e-06	5.67e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTGS2—kidney cancer	1.18e-06	5.66e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ABCB1—kidney cancer	1.17e-06	5.65e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—BRAF—kidney cancer	1.17e-06	5.62e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTGS1—kidney cancer	1.16e-06	5.61e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PSMD7—kidney cancer	1.14e-06	5.5e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSTM1—kidney cancer	1.14e-06	5.48e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CRABP1—kidney cancer	1.13e-06	5.45e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.09e-06	5.25e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—BCHE—kidney cancer	1.08e-06	5.21e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTP1—kidney cancer	1.08e-06	5.2e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYP1A1—kidney cancer	1.08e-06	5.2e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.07e-06	5.15e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTEN—kidney cancer	1.06e-06	5.12e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ITPR2—kidney cancer	1.05e-06	5.07e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MAPK3—kidney cancer	1.05e-06	5.04e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTGS2—kidney cancer	1.03e-06	4.98e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.03e-06	4.97e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTEN—kidney cancer	1.03e-06	4.94e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MYC—kidney cancer	1.02e-06	4.9e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1e-06	4.83e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MAPK1—kidney cancer	9.95e-07	4.79e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTGS2—kidney cancer	9.94e-07	4.78e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTM1—kidney cancer	9.92e-07	4.78e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—POMC—kidney cancer	9.89e-07	4.76e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—RAF1—kidney cancer	9.74e-07	4.69e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—ERBB2—kidney cancer	9.63e-07	4.64e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTT1—kidney cancer	9.59e-07	4.62e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ACHE—kidney cancer	9.59e-07	4.62e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MTOR—kidney cancer	9.51e-07	4.58e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CD4—kidney cancer	9.49e-07	4.57e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP1A1—kidney cancer	9.4e-07	4.53e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—KRAS—kidney cancer	9.4e-07	4.53e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—POMC—kidney cancer	9.31e-07	4.48e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—POMC—kidney cancer	9.29e-07	4.47e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PIK3CA—kidney cancer	9.23e-07	4.44e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SCARB1—kidney cancer	9.08e-07	4.37e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTEN—kidney cancer	9.02e-07	4.34e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTGS1—kidney cancer	8.99e-07	4.33e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN1B—kidney cancer	8.92e-07	4.3e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.87e-07	4.27e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PSMD7—kidney cancer	8.82e-07	4.25e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.74e-07	4.21e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTEN—kidney cancer	8.67e-07	4.17e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PIK3CA—kidney cancer	8.63e-07	4.16e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTP1—kidney cancer	8.62e-07	4.15e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CTNNB1—kidney cancer	8.43e-07	4.06e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—BCHE—kidney cancer	8.36e-07	4.02e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SLC5A5—kidney cancer	8.26e-07	3.98e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PTEN—kidney cancer	8.21e-07	3.96e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ABCB1—kidney cancer	8.16e-07	3.93e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—POMC—kidney cancer	8.05e-07	3.88e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SLC2A1—kidney cancer	7.97e-07	3.84e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTM1—kidney cancer	7.92e-07	3.81e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP1A1—kidney cancer	7.51e-07	3.61e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CA—kidney cancer	7.5e-07	3.61e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTGS2—kidney cancer	7.43e-07	3.58e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTGS2—kidney cancer	7.41e-07	3.57e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CA—kidney cancer	7.23e-07	3.48e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MAPK3—kidney cancer	7.02e-07	3.38e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—POMC—kidney cancer	7.01e-07	3.38e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PTEN—kidney cancer	6.88e-07	3.31e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MYC—kidney cancer	6.83e-07	3.29e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MAPK1—kidney cancer	6.68e-07	3.22e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTP1—kidney cancer	6.65e-07	3.2e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTEN—kidney cancer	6.48e-07	3.12e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTEN—kidney cancer	6.46e-07	3.11e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTGS2—kidney cancer	6.42e-07	3.09e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CA—kidney cancer	6.36e-07	3.06e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—KRAS—kidney cancer	6.31e-07	3.04e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ABCB1—kidney cancer	6.29e-07	3.03e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.17e-07	2.97e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CA—kidney cancer	6.11e-07	2.94e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTM1—kidney cancer	6.11e-07	2.94e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CA—kidney cancer	5.8e-07	2.79e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.79e-07	2.79e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTEN—kidney cancer	5.6e-07	2.7e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—POMC—kidney cancer	5.6e-07	2.7e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTGS2—kidney cancer	5.59e-07	2.69e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTEN—kidney cancer	4.88e-07	2.35e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CA—kidney cancer	4.85e-07	2.34e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CA—kidney cancer	4.57e-07	2.2e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CA—kidney cancer	4.56e-07	2.2e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTGS2—kidney cancer	4.46e-07	2.15e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—POMC—kidney cancer	4.32e-07	2.08e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CA—kidney cancer	3.95e-07	1.9e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTEN—kidney cancer	3.89e-07	1.87e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTGS2—kidney cancer	3.45e-07	1.66e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CA—kidney cancer	3.44e-07	1.66e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTEN—kidney cancer	3e-07	1.45e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CA—kidney cancer	2.75e-07	1.32e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.12e-07	1.02e-05	CbGpPWpGaD
